Similar Items: Soluble tumor necrosis factor receptors in diabetes: risk sensing and receptor-resolved targeting
- Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy
- Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
- Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
- The role of circulating tumor DNA in ovarian cancer
- IGF-2-mediated hypoglycemia in a patient with a phyllodes tumor of the breast: a rare presentation of non-islet cell tumor hypoglycemia
- Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency Presented With Leydig Cell Tumor and Testicular Adrenal Rest Tumors: A Case Report